应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
HURA TuHURA Biosciences, Inc.
盘前交易 05-08 08:10:30 EDT
3.80
+0.07
+1.88%
盘前
3.80
+0.00
0.00%
08:00 EDT
最高
3.98
最低
3.61
成交量
9.23万
今开
3.87
昨收
3.73
日振幅
9.92%
总市值
1.66亿
流通市值
8,089万
总股本
4,368万
成交额
34.74万
换手率
0.43%
流通股本
2,129万
市净率
11.59
ROE
-332.67%
每股收益
-1.21
52周最高
14.60
52周最低
1.80
市盈率
-3.13
股息
0.00
股息收益率
0.00
ROA
-90.68%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
TuHURA Biosciences(HURA.US)获HC Wainwright & Co.首次覆盖,给予买入评级, 目标价13.00美元。
金融界 · 03-03
TuHURA Biosciences(HURA.US)获HC Wainwright & Co.首次覆盖,给予买入评级, 目标价13.00美元。
加载更多
公司概况
公司名称:
TuHURA Biosciences, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
TuHURA Biosciences, Inc.是一家内华达州公司,成立于2009年6月24日,名称为Berry Only,Inc。该公司是一家临床阶段的生物制药公司。Kintara致力于为医疗需求未得到满足的患者开发新型癌症疗法。Kintara公司正在开发两种晚期疗法,以降低风险,满足明确的未满足的医疗需求。这两个项目分别是VAL-083治疗胶质母细胞瘤(GBM)和REM-001治疗皮肤转移性乳腺癌(CMBC)。
发行价格:
--
{"stockData":{"symbol":"HURA","market":"US","secType":"STK","nameCN":"TuHURA Biosciences, Inc.","latestPrice":3.8,"timestamp":1746648000000,"preClose":3.73,"halted":0,"volume":92258,"hourTrading":{"tag":"盘前","latestPrice":3.8,"preClose":3.8,"latestTime":"08:00 EDT","volume":87,"amount":330.59999999999997,"timestamp":1746705600905},"delay":0,"floatShares":21286907,"shares":43680397,"eps":-1.213628,"marketStatus":"盘前交易","change":0.07,"latestTime":"05-08 08:10:28 EDT","open":3.87,"high":3.98,"low":3.61,"amount":347352.6339346,"amplitude":0.099196,"askPrice":4.34,"askSize":100,"bidPrice":3.3,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.213628,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746711000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":3.8,"preHourTrading":{"tag":"盘前","latestPrice":3.8,"preClose":3.8,"latestTime":"08:00 EDT","volume":87,"amount":330.59999999999997,"timestamp":1746705600905},"postHourTrading":{"tag":"盘后","latestPrice":3.8,"preClose":3.8,"latestTime":"19:42 EDT","volume":54,"amount":205.13,"timestamp":1746661375195},"volumeRatio":1.0265031823905166},"requestUrl":"/m/hq/s/HURA","defaultTab":"news","newsList":[{"id":"2516049635","title":"TuHURA Biosciences(HURA.US)获HC Wainwright & Co.首次覆盖,给予买入评级, 目标价13.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516049635","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516049635?lang=zh_cn&edition=full","pubTime":"2025-03-03 21:20","pubTimestamp":1741008040,"startTime":"0","endTime":"0","summary":"TuHURA Biosciences(HURA.US)获HC Wainwright & Co.首次覆盖,给予买入评级, 目标价13.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/03212048493051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["HURA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kintara.com","stockEarnings":[{"period":"1week","weight":0.0053},{"period":"1month","weight":0.044},{"period":"3month","weight":-0.148},{"period":"6month","weight":-0.2276},{"period":"1year","weight":-0.2936},{"period":"ytd","weight":-0.0709}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.1126},{"period":"3month","weight":-0.0745},{"period":"6month","weight":-0.0619},{"period":"1year","weight":0.0851},{"period":"ytd","weight":-0.0425}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TuHURA Biosciences, Inc.是一家内华达州公司,成立于2009年6月24日,名称为Berry Only,Inc。该公司是一家临床阶段的生物制药公司。Kintara致力于为医疗需求未得到满足的患者开发新型癌症疗法。Kintara公司正在开发两种晚期疗法,以降低风险,满足明确的未满足的医疗需求。这两个项目分别是VAL-083治疗胶质母细胞瘤(GBM)和REM-001治疗皮肤转移性乳腺癌(CMBC)。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.09362},{"month":2,"riseRate":0.111111,"avgChangeRate":-0.150578},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.000318},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.030862},{"month":5,"riseRate":0.666667,"avgChangeRate":1.219895},{"month":6,"riseRate":0.5,"avgChangeRate":-0.011708},{"month":7,"riseRate":0.375,"avgChangeRate":-0.030517},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.105627},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.105678},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.132105},{"month":11,"riseRate":0.444444,"avgChangeRate":-0.051736},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.176189}],"exchange":"NASDAQ","name":"TuHURA Biosciences, Inc.","nameEN":"TuHURA Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TuHURA Biosciences, Inc.(HURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TuHURA Biosciences, Inc.(HURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TuHURA Biosciences, Inc.,HURA,TuHURA Biosciences, Inc.股票,TuHURA Biosciences, Inc.股票老虎,TuHURA Biosciences, Inc.股票老虎国际,TuHURA Biosciences, Inc.行情,TuHURA Biosciences, Inc.股票行情,TuHURA Biosciences, Inc.股价,TuHURA Biosciences, Inc.股市,TuHURA Biosciences, Inc.股票价格,TuHURA Biosciences, Inc.股票交易,TuHURA Biosciences, Inc.股票购买,TuHURA Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TuHURA Biosciences, Inc.(HURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TuHURA Biosciences, Inc.(HURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}